Oral small-molecule GLP-1 receptor agonist for obesity in people from Japan. // The Lancet Diabetes & Endocrinology. – URL: https://www.sciencedirect.com/science/article/pii/S2213858726002536?dgcid=rss_sd_all
Oral small-molecule GLP-1 receptor agonist for obesity in people from Japan. The Lancet Diabetes & Endocrinology. https://www.sciencedirect.com/science/article/pii/S2213858726002536?dgcid=rss_sd_all
“Oral small-molecule GLP-1 receptor agonist for obesity in people from Japan.” The Lancet Diabetes & Endocrinology.
@article{article68482,
title = {Oral small-molecule GLP-1 receptor agonist for obesity in people from Japan},
journal = {The Lancet Diabetes \& Endocrinology},
url = {https://www.sciencedirect.com/science/article/pii/S2213858726002536?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...